Browsing by Author "Alarco, Walter"

Now showing items 1-4 of 4

    • Advancing cardiac care: a registry of heart transplantation in Latin America (1968-2022) 
      Uribe Buritica, Francisco L.; Olaya, Pastor; Rivera, Edilma Lucy; Cimbaro, Juan Pablo; Barisani, José Luis; Schwartzmann, Pedro; Bacal, Fernando; Rossel Mariángel, Víctor; Garita Jiménez, Elliott; Nafeh Abi-Rezk, Manuel; Cigarroa, Josá Ángel; Herrera Garza, Eduardo Heberto; Díaz Lezcano, Temístocles; Nery Fernández, Felipe; Alarco, Walter; Banchs Pieretti, Héctor; Núñez, Elaine; Pereda, Maximiliano; Pow Chon Long, Freddy; Castillo González, Eglee; Gómez Mesa, Juan Esteban (Elsevier, 2024)
      Introduction. Heart transplantation (HTx) has emerged as a pivotal intervention for end-stage heart failure, offering significant improvements in survival and quality of life. This manuscript elucidates the landscape of ...
    • American registry of ambulatory and acute decompensated heart failure (AMERICCAASS registry): rationale and design 
      Gómez Mesa, Juan Esteban; Gutiérrez Posso, Juliana María; Escalante Forero, Manuela; Eraso Bolaños, David Esteban; Drazner, Mark H.; Quesada Chaves, Daniel; Romero Guerra, Alexander; Perna, Eduardo R.; Álvarez Sangabriel, Amada; Rossel Mariángel, Víctor; Alarco, Walter; Speranza, Mario (Wiley, 2024)
      Aims Heart failure (HF) is a highly prevalent and progressive condition associated with significant morbidity and mortalityrates. Acute decompensated HF precipitates millions of hospitalizations each year. Despite therapeutic ...
    • Documento de consenso sobre el uso de sacubitrilo/valsartán en pacientes con insuficiencia cardiaca: Consejo ... 
      Speranza, Mario; Saldarriaga, Clara; Ramos, Carlos E.; Quesada, Daniel; Rossel Mariángel, Víctor; Ventura Umanzor, Jaime R.; Pow-Chon, Freddy; Alarco, Walter; Figueroa, Yolanda; Magaña, Antonio; Gómez Mesa, Juan E.; Rodríguez García, David (Permanyer, 2023)
      La insuficiencia cardiaca (IC) es un evento significativo para la salud pública. Tiene una prevalencia entre el 1 y 2%, tasa de mortalidad entre el 7 y 17% y de hospitalización entre el 32 y 44%. Esto implica un riesgo a ...
    • Pharmacological treatment for pulmonary arterial hypertension: availability and access in Latin America and ... 
      Uribe, Francisco; Gómez Mesa, Juan; Escalante, Manuela; Speranza, Mario; Nicaragua Hurtado, Pablo; Perna, Eduardo; Rivera, Alex; Romero Guerra, Alexander; Rossel Mariángel, Víctor; Alarco, Walter (Churchill Livingstone Inc Medical Publishers, 2024)
      Introduction The management of Pulmonary Arterial Hypertension (PAH) includes pharmacological and surgical strategies to control symptoms and increase survival. Current management guidelines provide recommendations about ...